17 related articles for article (PubMed ID: 21767920)
1. MGMT and PTEN as potential prognostic markers in breast cancer.
Neto JC; Ikoma MM; Carvalho KC; Vassallo J; De Brot M; Gobbi H; Soares FA; Rocha RM
Exp Mol Pathol; 2012 Feb; 92(1):20-6. PubMed ID: 22019339
[TBL] [Abstract][Full Text] [Related]
2. Role of kisspeptin/GPR54 in the first trimester trophoblast of women with a history of recurrent spontaneous abortion.
Li L; Tian J; Zhou L; Wu S; Zhang S; Qi L; Zhang H
Int J Clin Exp Pathol; 2017; 10(8):8161-8173. PubMed ID: 31966668
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of DNA methyltransferase 1 (DNMT1) protein in astrocytic tumour and its correlation with O6-methylguanine-DNA methyltransferase (MGMT) expression.
Rahman WF; Rahman KS; Nafi SN; Fauzi MH; Jaafar H
Int J Clin Exp Pathol; 2015; 8(6):6095-106. PubMed ID: 26261487
[TBL] [Abstract][Full Text] [Related]
4. Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis.
Sasai K; Nodagashira M; Nishihara H; Aoyanagi E; Wang L; Katoh M; Murata J; Ozaki Y; Ito T; Fujimoto S; Kaneko S; Nagashima K; Tanaka S
Am J Surg Pathol; 2008 Aug; 32(8):1220-7. PubMed ID: 18580490
[TBL] [Abstract][Full Text] [Related]
5. Quantitative digital assessment of MGMT immunohistochemical expression in glioblastoma tissue.
Araki Y; Mizoguchi M; Yoshimoto K; Shono T; Amano T; Nakamizo A; Suzuki SO; Iwaki T; Sasaki T
Brain Tumor Pathol; 2011 Feb; 28(1):25-31. PubMed ID: 21249460
[TBL] [Abstract][Full Text] [Related]
6. The prognostic impact of O6-methylguanine DNA methyltransferase and epidermal growth factor receptor expressions on primary gliosarcoma: a clinicopathologic and immunohistochemical study of seven cases at a single institution.
Lin JW; Wu YT; Chang IW
Indian J Pathol Microbiol; 2011; 54(4):683-7. PubMed ID: 22234090
[TBL] [Abstract][Full Text] [Related]
7. Pitfalls in the assessment of MGMT expression and in its correlation with survival in diffuse astrocytomas: proposal of a feasible immunohistochemical approach.
Capper D; Mittelbronn M; Meyermann R; Schittenhelm J
Acta Neuropathol; 2008 Feb; 115(2):249-59. PubMed ID: 17965865
[TBL] [Abstract][Full Text] [Related]
8. O-6-methylguanine-DNA methyltransferase (MGMT) immunohistochemical expression in pituitary corticotroph adenomas.
Salehi F; Scheithauer BW; Kovacs K; Horvath E; Syro LV; Sharma S; Manoranjan B; Cusimano M
Neurosurgery; 2012 Feb; 70(2):491-6; discussion 496. PubMed ID: 21822153
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of O6-methylguanine-DNA methyltransferase by immunohistochemistry: best clinical and research practices.
Neto JC; Carvalho K; Olivieri E; Carraro D; Cunha I; Vassallo J; Kagohara L; Soares F; Rocha R
Pathol Res Pract; 2011 Aug; 207(8):492-7. PubMed ID: 21767920
[TBL] [Abstract][Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
